In acknowledgment of her research advancing the field of cardiovascular science, UTHealth Houston’s Louise McCullough, MD, PhD, has been honored with the 2022 American Heart Association Basic Research Prize.
Patients diagnosed with cancer more than one year ago and those not receiving active treatment were no more vulnerable to worse COVID-19 outcomes than patients without cancer, according to a new study led by UTHealth Houston.
It’s no secret that vitamin D is critical to balancing many areas of health. But from pediatric broken bones to cluster headaches, physicians and scientists at The University of Texas Health Science Center at Houston (UTHealth Houston) are still learning just how powerful the so-called “sunshine vitamin” is.
Her scientific leadership in the laboratory studying sex differences in stroke severity and outcomes is among the reasons why Louise McCullough, MD, PhD, received the 2021 C. Miller Fisher, MD Neuroscience Visionary Award from the American Heart Association/American Stroke Association (AHA/ASA).
Boosting a family of naturally occurring proteins that dampens inflammation in the body has been shown to be effective in reducing damage from an ischemic stroke, according to preclinical researchers at The University of Texas Health Science Center at Houston (UTHealth).
Exoskeleton-assisted rehabilitation can be beneficial in treating stroke survivors, according to researchers at The University of Texas Health Science Center at Houston (UTHealth).
Unraveling the links among obesity, aging, telomere lengths and metabolic diseases is the subject of the study published today in Nature Metabolism by a collaborative research team at The University of Texas Health Science Center at Houston (UTHealth).
Gustavo Oderich, MD, FACS, a noted leader in the field of vascular and endovascular surgery, has been named chief of the vascular surgery division with the Department of Cardiothoracic and Vascular Surgery at The University of Texas Health Science Center at Houston (UTHealth). He will serve as professor of vascular and endovascular surgery at McGovern Medical School at UTHealth and director of the Advanced Endovascular Aortic Program.
Using a multimillion-dollar grant from the NIH, physician-scientists at The University of Texas Health Science Center at Houston (UTHealth) will investigate whether convalescent plasma infusions can prevent the progression of COVID-19 in one of the first randomized clinical trials in the country.
Congenital heart disease, which used to be considered a death sentence, is now a managed disease for adults thanks to advances in medicine and specialized programs such as the Adult Congenital Heart Disease Program at The University of Texas Health…